Open AccessWhen cardiomyopathy, cancer, and COVID‐19 collide: A case report
Author(s) -
Symonds Lynn,
Natarajan Poorna,
Cheng Richard K.,
Lam Diana L.,
Kilgore Mark,
Kim Janice,
Calhoun Kristine,
Minami Elina,
Gralow Julie R.
Publication year - 2021
Publication title -
the breast journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.533
H-Index - 72
eISSN - 1524-4741
pISSN - 1075-122X
DOI - 10.1111/tbj.14182
Subject(s) - medicine , malignancy , breast cancer , lumpectomy , cancer , heart transplantation , covid-19 , intensive care medicine , cardiomyopathy , oncology , heart failure , mastectomy , disease , infectious disease (medical specialty)
Malignancy has historically prohibited solid organ transplant; however, patients with effectively treated, favorable‐risk cancers should not necessarily be eliminated as transplant candidates. These cases require careful review by a multidisciplinary team. Here, we report the case of a woman with end‐stage heart failure undergoing heart transplant evaluation during the COVID pandemic who was found to have early‐stage, hormone receptor‐positive breast cancer. Given her favorable cancer‐related prognosis, a multidisciplinary committee recommended lumpectomy, accelerated partial breast irradiation, and adjuvant aromatase inhibitor therapy for definitive treatment to allow for consideration of orthotopic heart transplant.